Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer

World Journal of Surgery

Volumn 33, Issue 12, 2009, Pages 2688-2694

  Cho, Yong Beom ^a   Chun, Ho Kyung ^a   Kim, Min Ju ^b   Choi, Joon Young ^a   Park, Chi Min ^a   Kim, Byung Tae ^a   Lee, Soon Jin ^a   Yun, Seong Hyeon ^a   Kim, Hee Cheol ^a   Lee, Woo Yong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECTUM TUMOR;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956065029     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/S00268-009-0248-3     Document Type: Conference Paper

References (42)

1. Theodoropoulos G, Wise WE, Padmanabhan A et al (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45:895-903
2. Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664-674
3. Onaitis MW, Noone RB, Hartwig M et al (2001) Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 233:778-785
4. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
5. Kwok H, Bissett IP, Hill GL (2000) Preoperative staging of rectal cancer. Int J Colorectal Dis 15:9-20
6. Maier A, Fuchsjager M (2003) Preoperative staging of rectal cancer. Eur J Radiol 47:89-97
7. Holzer B, Urban M, Holbling N et al (2003) Magnetic resonance imaging predicts sphincter invasion of low rectal cancer and influences selection of operation. Surgery 133:656-661
8. Staib L, Schirrmeister H, Reske SN et al (2000) Is (18)F- fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 180:1-5
9. Ogunbiyi OA, Flanagan FL, Dehdashti F et al (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613-620
10. Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815-822
11. Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of highspatial-resolution MR imaging with histopathologic comparison. Radiology 227:371-377
12. Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury, New York, pp 407-410
13. Medical Research Council Rectal Cancer Working Party (1996) Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348:1605-1610
14. Mohiuddin M, Regine WF, Marks GJ et al (1998) High-dose preoperative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys 40:569-574
15. Amthauer H, Denecke T, Rau B et al (2004) Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31:811-819
16. Hunerbein M, Totkas S, Ghadimi BM et al (2000) Preoperative evaluation of colorectal neoplasms by colonoscopic miniprobe ultrasonography. Ann Surg 232:46-50
17. Beets-Tan RG, Beets GL, Borstlap AC et al (2000) Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging 25:533-541
18. Rau B, Hunerbein M, Barth C et al (1999) Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endosc 13:980-984
19. Kuo LJ, Chern MC, Tsou MH et al (2005) Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 48:23-28
20. Pegios W, Vogl J, Mack MG et al (1996) MRI diagnosis and staging of rectal carcinoma. Abdom Imaging 21:211-218
21. Zagoria RJ, Schlarb CA, Ott DJ et al (1997) Assessment of rectal tumor infiltration utilizing endorectal MR imaging and comparison with endoscopic rectal sonography. J Surg Oncol 64:312-317
22. Kim NK, Kim MJ, Park JK et al (2000) Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 7:732-737
23. Maldjian C, Smith R, Kilger A et al (2000) Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: a comparison study to rectal endosonography. Abdom Imaging 25:75-80
24. Blomqvist L, Holm T, Nyren S et al (2002) MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol 57:211-218
25. Gagliardi G, Bayar S, Smith R et al (2002) Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg 137:447-451
26. Hoffmann KT, Rau B, Wust P et al (2002) Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 178:386-392
27. Schroder RJ, Pegios W, Hunerbein M et al (1997) Magnetic resonance tomography and endosonography in the preoperative staging of advanced rectal carcinomas after hyperthermoradiochemotherapy. Rofo 166:199-205
28. Semelka RC, Hussain SM, Marcos HB et al (2000) Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. Radiology 215:89-94
29. Fielding LP, Phillips RK, Fry JS et al (1986) Prediction of outcome after curative resection for large bowel cancer. Lancet 2:904-907
30. Vogl TJ, Pegios W, Mack MG et al (1997) Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging. AJR Am J Roentgenol 168:1427-1434
31. Koh DM, Brown G, Temple L et al (2004) Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 231:91-99
32. Huebner RH, Park KC, Shepherd JE et al (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41:1177-1189
33. Flier JS, Mueckler MM, Usher P et al (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492-1495
34. Calvo FA, Domper M, Matute R et al (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528-535
35. Guillem JG, Moore HG, Akhurst T et al (2004) Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199:1-7
36. Young H, Baum R, Cremerius U et al (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1773-1782
37. Hamberg LM, Hunter GJ, Alpert NM et al (1994) The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 35:1308-1312
38. Capirci C, Rubello D, Chierichetti F et al (2004) Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother 58:451-457
39. Abdel-Nabi H, Doerr RJ, Lamonica DM et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755-760
40. Ruers TJ, Langenhoff BS, Neeleman N et al (2002) Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388-395
41. Fong Y, Saldinger PF, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282-287
42. Whiteford MH, Whiteford HM, Yee LF et al (2000) Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759-767 discussion 767-770